Reports from the American Society for Clinical Oncology Gastrointestinal Cancers Conference, the Princess Margaret Cancer Conference and the Canadian Melanoma Conference
Timing of surgery after radiation
Testing ramucirumab + FOLFIRI as second-line therapy
Dr. Tak Mak and Dr. Kim Chi debate: Will immunotherapy double cancer-specific survival compared to molecular targeted therapies in the next 10 years?
A summary of key presentations